Werkgroep Cardiologische centra Nederland

Emphasis (Completed)

A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines (EMPHASIS-HF)
Medicine
inspra (eplerenone)
Population
Heart failure
Phase
III
Starting year
2005
More information
ClinicalTrials.gov

Emphasis: News